News | Press Releases

For Immediate Release Contact marketingcommunications@us.medical.canon

November 30, 2014

Toshiba Puts Customers First with Diagnostic Imaging Innovations

A New Product Introduction in Every Modality at RSNA

CHICAGO, Nov. 30, 2014 – Toshiba America Medical Systems, Inc. understands its customers’ business and is introducing a new system in every modality at RSNA, allowing its customers to provide better care more efficiently. These new products are a part of Toshiba Group’s overall commitment to healthcare that strives to control costs with more effective diagnoses and treatments.

“Better health, better healthcare and at a lower cost is the ‘triple aim’ of healthcare reform, and our new product innovations provide solutions that help our customers meet that goal,” said Nancy Gillen, vice president, Marketing and Business Management, Toshiba. “By understanding our customers’ business, we are constantly developing new technologies that facilitate faster and safer diagnoses at lower costs.”

Toshiba’s multimodality approach to innovation in patient care includes the rollout of the following products:

  • InfinixTM 4DCT system*: Challenges the status quo in minimally invasive care by seamlessly integrating CT and IR into one solution
  • AplioTM 300 and 500 Platinum Series ultrasound systems: Provides a wide range of powerful imaging and interventional tools to expand the clinical applications of ultrasound and standardize care
  • ElanTM MR system (pending 510(k) clearance): Offers outstanding image quality and patient comfort features typically found on more expensive systems and has the smallest footprint in its class
  • CelesteionTM PET/CT system: Combines high-performance PET and CT for all radiation oncology imaging needs and delivers a more comfortable exam with the industry’s largest bore
  • KalareTM Flat Panel Detector: Reduces scatter radiation by up to 95 percent with its integrated tube covers and provides high-quality images edge to edge without an increase in dose

Toshiba is unveiling these products at this year’s Radiological Society of North America (RSNA) annual meeting in Chicago, Nov. 30 – Dec. 5, 2014 (Booth #7333, North Hall).

About Toshiba America Medical Systems, Inc.

With headquarters in Tustin, Calif., Toshiba America Medical Systems (TAMS) markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and cardiovascular equipment, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit the TAMS website at www.medical.toshiba.com.

About Toshiba Medical Systems Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba. Visit Toshiba Medical Systems Corporation’s website at www.toshibamedicalsystems.com.

About Toshiba

Toshiba Corporation, a Fortune 500 company, channels world-class capabilities in advanced electronic and electrical products and systems into five strategic business domains: Energy & Infrastructure, Community Solutions, Healthcare Systems & Services, Electronic Devices & Components, and Lifestyles Products & Services. Guided by the principles of The Basic Commitment of the Toshiba Group, “Committed to People, Committed to the Future,” Toshiba promotes global operations towards securing “Growth Through Creativity and Innovation” and is contributing to the achievement of a world in which people everywhere live in a safe, secure and comfortable society.

Founded in Tokyo in 1875, today’s Toshiba is at the heart of a global network of over 590 consolidated companies employing over 200,000 people worldwide, with annual sales surpassing 6.5 trillion yen (US$63 billion). To find out more about Toshiba, visit www.toshiba.co.jp/index.htm.

###

*Currently the system is FDA cleared with the Infinix Elite and AquilionTM ONE ViSION Edition configuration. It is (pending 510(k) clearance) for use with the Aquilion PRIME CT system.